Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI).
Publication
, Journal Article
Sharma, A; Kaiser, PK; Tadayoni, R; Holz, FG; Nicholson, L; Vazquez-Alfageme, C; Sivaprasad, S; Wakabayashi, T; Woo, SJ; Sarraf, D; Kumar, N ...
Published in: Eye (Lond)
December 2024
Duke Scholars
Published In
Eye (Lond)
DOI
EISSN
1476-5454
Publication Date
December 2024
Volume
38
Issue
17
Start / End Page
3392 / 3395
Location
England
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
- 3204 Immunology
- 1113 Opthalmology and Optometry
- 1107 Immunology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sharma, A., Kaiser, P. K., Tadayoni, R., Holz, F. G., Nicholson, L., Vazquez-Alfageme, C., … International Retina Biosimilar Study Group (Inter BIOS Group). (2024). Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI). Eye (Lond), 38(17), 3392–3395. https://doi.org/10.1038/s41433-024-03284-x
Sharma, Ashish, Peter K. Kaiser, Ramin Tadayoni, Frank G. Holz, Luke Nicholson, Clara Vazquez-Alfageme, Sobha Sivaprasad, et al. “Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI).” Eye (Lond) 38, no. 17 (December 2024): 3392–95. https://doi.org/10.1038/s41433-024-03284-x.
Sharma A, Kaiser PK, Tadayoni R, Holz FG, Nicholson L, Vazquez-Alfageme C, et al. Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI). Eye (Lond). 2024 Dec;38(17):3392–5.
Sharma, Ashish, et al. “Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI).” Eye (Lond), vol. 38, no. 17, Dec. 2024, pp. 3392–95. Pubmed, doi:10.1038/s41433-024-03284-x.
Sharma A, Kaiser PK, Tadayoni R, Holz FG, Nicholson L, Vazquez-Alfageme C, Sivaprasad S, Wakabayashi T, Woo SJ, Sarraf D, Kumar N, Parachuri N, Regillo CD, Rezaei KA, Khanani AM, Bandello F, Shanamugam M, Verma L, Dogra MR, Ns M, Agarwal M, Loewenstein A, Kuppermann BD, International Retina Biosimilar Study Group (Inter BIOS Group). Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI). Eye (Lond). 2024 Dec;38(17):3392–3395.
Published In
Eye (Lond)
DOI
EISSN
1476-5454
Publication Date
December 2024
Volume
38
Issue
17
Start / End Page
3392 / 3395
Location
England
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
- 3204 Immunology
- 1113 Opthalmology and Optometry
- 1107 Immunology
- 1103 Clinical Sciences